1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Cabozantinib for untreated advanced renal cell carcinoma

Technology appraisal guidance [TA542] Published: 03 October 2018

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 230 KB 03 October 2018  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 371 KB 24 August 2018  
  • Committee papers PDF 2.2 MB 24 August 2018  
  • Public committee slides PDF 467 KB 24 August 2018  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 385 KB 05 June 2018  
  • Committee papers PDF 19.33 MB 05 June 2018  
  • Public committee slides PDF 871 KB 05 June 2018  

Invitation to participate

  • Final scope PDF 84 KB 05 December 2017  
  • Final matrix PDF 260 KB 05 December 2017  
  • NICE's response to comments on the draft scope and provisional matrix PDF 117 KB 05 December 2017  
  • Equality impact assessment (Scoping) PDF 172 KB 05 December 2017  

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators  
  • Draft scope post referral PDF 241 KB 05 September 2017  
  • Draft matrix post referral PDF 261 KB 05 September 2017